1. Field of the Invention
The present invention relates to a process for converting lower molecular weight, gaseous alkanes to liquid hydrocarbons useful for the production of fuels, and more particularly, to a process wherein a gas containing lower molecular weight alkanes is reacted with a dry bromine vapor to form alkyl bromides and hydrobromic acid which in turn are reacted over a crystalline alumino-silicate catalyst to form liquid hydrocarbons.
2. Description of Related Art
Natural gas which is primarily composed of methane and other light alkanes has been discovered in large quantities throughout the world. Many of the locales in which natural gas has been discovered are far from populated regions which have significant gas pipeline infrastructure or market demand for natural gas. Due to the low density of natural gas, transportation thereof in gaseous form by pipeline or as compressed gas in vessels is expensive. Accordingly, practical and economic limits exist to the distance over which natural gas may be transported in gaseous form. Cryogenic liquefaction of natural gas (LNG) is often used to more economically transport natural gas over large distances. However, this LNG process is expensive and there are limited regasification facilities in only a few countries that are equipped to import LNG.
Another use of methane found in natural gas is as feed to processes for the production of methanol. Methanol is made commercially via conversion of methane to synthesis gas (CO and H2) at high temperatures (approximately 1000° C.) followed by synthesis at high pressures (approximately 100 atmospheres). There are several types of technologies for the production of synthesis gas (CO and H2) from methane. Among these are steam-methane reforming (SMR), partial oxidation (POX), autothermal reforming (ATR), gas-heated reforming (GHR), and various combinations thereof. SMR and GHR operate at high pressures and temperatures, generally in excess of 600° C., and require expensive furnaces or reactors containing special heat and corrosion-resistant alloy tubes filled with expensive reforming catalyst. POX and ATR processes operate at high pressures and even higher temperatures, generally in excess of 1000° C. As there are no known practical metals or alloys that can operate at these temperatures, complex and costly refractory-lined reactors and high-pressure waste-heat boilers to quench & cool the synthesis gas effluent are required. Also, significant capital cost and large amounts of power are required for compression of oxygen or air to these high-pressure processes. Thus, due to the high temperatures and pressures involved, synthesis gas technology is expensive, resulting in a high cost methanol product which limits higher-value uses thereof, such as for chemical feedstocks and solvents. Furthermore production of synthesis gas is thermodynamically and chemically inefficient, producing large excesses of waste heat and unwanted carbon dioxide, which tends to lower the conversion efficiency of the overall process. Fischer-Tropsch Gas-to-Liquids (GTL) technology can also be used to convert synthesis gas to heavier liquid hydrocarbons, however investment cost for this process is even higher. In each case, the production of synthesis gas represents a large fraction of the capital costs for these methane conversion processes.
Numerous alternatives to the conventional production of synthesis gas as a route to methanol or synthetic liquid hydrocarbons have been proposed. However, to date, none of these alternatives has attained commercial status for various reasons. Some of the previous alternative prior-art methods, such as disclosed in U.S. Pat. Nos. 5,243,098 or 5,334,777 to Miller, teach reacting a lower alkane, such as methane, with a metallic halide to form a metalous halide and hydrohalic acid which are in turn reduced with magnesium oxide to form the corresponding alkanol. However, halogenation of methane using chlorine as the preferred halogen results in poor selectivity to the monomethyl halide (CH3Cl), resulting in unwanted by-products such as CH2Cl2 and CHCl3 which are difficult to convert or require severe limitation of conversion per pass and hence very high recycle rates. Furthermore, these processes require movement and fluidization of solid metal salts and/or oxides which requires significant power, causes erosion of equipment and generation of fine dust which must be recovered and recycled.
Other prior art processes propose the catalytic chlorination or bromination of methane as an alternative to generation of synthesis gas (CO and H2). To improve the selectivity of a methane halogenation step in an overall process for the production of methanol, U.S. Pat. No. 5,998,679 to Miller teaches the use of bromine, generated by thermal decomposition of a metal bromide, to brominate alkanes in the presence of excess alkanes, which results in improved selectivity to mono-halogenated intermediates such as methyl bromide. To avoid the drawbacks of utilizing fluidized beds of moving solids, the process utilizes a liquid mixture of metal chloride hydrates and metal bromides. Processes described in U.S. Pat. Nos. 6,462,243 B1, 6,472,572 B1, and 6,525,230 to Grosso are capable of attaining higher selectivity to mono-halogenated intermediates by the use of catalytic bromination. The resulting alkyl bromides intermediates such as methyl bromide, are further converted to the corresponding alcohols and ethers, by reaction with metal oxides in circulating beds of moving solids, with the drawbacks that beds of moving solids entail as described above. Another embodiment of U.S. Pat. No. 6,525,230 avoids the drawbacks of moving beds by utilizing a zoned reactor vessel containing a fixed bed of metal oxide/metal bromide that is operated cyclically in four steps. Additional drawbacks to the processes described in these patents are the simultaneous feeding of hydrocarbon gas and oxygen or air to a reactor vessel increasing the potential of an explosive condition occurring within the equipment in the event of an unanticipated process upset or mechanical failure. Also, these processes tend to produce substantial quantities of dimethylether (DME) along with any alcohol. While DME is a promising potential diesel engine fuel substitute, as of yet, there currently exists no substantial market for DME, and hence an expensive additional catalytic process conversion step would be required to convert DME into a currently marketable product. Other processes have been proposed which circumvent the need for production of synthesis gas, such as U.S. Pat. Nos. 4,655,893 and 4,467,130 to Olah in which methane is catalytically condensed into gasoline-range hydrocarbons via catalytic condensation using superacid catalysts. However, none of these earlier alternative approaches have resulted in commercial processes.
It is known that substituted alkanes, in particular methanol, can be converted to olefins and gasoline boiling-range hydrocarbons over various forms of crystalline alumino-silicates also known as zeolites. In the Methanol to Gasoline (MTG) process, a shape selective zeolite catalyst, ZSM-5, is used to convert methanol to gasoline. Coal or methane gas can thus be converted to methanol using conventional technology and subsequently converted to gasoline. However due to the high cost of methanol production, and at current or projected prices for gasoline, the MTG process is not considered economically viable. Thus, a need exists for an economic process for the conversion of methane and other alkanes found in natural gas to useful liquid hydrocarbon products which, due to their higher density and value, are more economically transported thereby significantly aiding development of remote natural gas reserves. A further need exists for a process for converting alkanes present in natural gas which is relatively inexpensive, safe and simple in operation.
To achieve the foregoing and other objects, and in accordance with the purposes of the present invention, as embodied and broadly described herein, one characterization of the present invention is a process for converting gaseous alkanes to liquid hydrocarbons. A gaseous feed having lower molecular weight alkanes is reacted with bromine vapor to form alkyl bromides and hydrobromic acid which in turn are reacted in the presence of a synthetic crystalline alumino-silicate catalyst and at a temperature sufficient to form higher molecular weight hydrocarbons and hydrobromic acid vapor.
In another characterization of the present invention, a process is provided for converting gaseous lower molecular weight alkanes to liquid hydrocarbons wherein a gaseous feed containing lower molecular weight alkanes is reacted with bromine vapor to form alkyl bromides and hydrobromic acid. The alkyl bromides and hydrobromic acid are reacted in the presence of a synthetic crystalline alumino-silicate catalyst to form higher molecular weight hydrocarbons and hydrobromic acid vapor. Bromine is recovered from the hydrobromic acid vapor.
The accompanying drawings, which are incorporated in and form a part of the specification, illustrate the embodiments of the present invention and, together with the description, serve to explain the principles of the invention.
In the drawings:
As utilized throughout this description, the term “lower molecular weight alkanes” refers to methane, ethane, propane, butane, pentane or mixtures thereof. As also utilized throughout this description, “alkyl bromides” refers to mono, di, and tri brominated alkanes. Also, the feed gas in lines 11 and 111 in the embodiments of the process of the present invention as illustrated in
A block flow diagram generally depicting the process of the present invention is illustrated in
In first reactor 30, the lower molecular weight alkanes are reacted exothermically with dry bromine vapor at a relatively low temperature in the range of about 250° C. to about 600° C., and at a pressure in the range of about 1 bar to about 30 bar to produce gaseous alkyl bromides and hydrobromic acid vapors. The upper limit of the operating temperature range is greater than the upper limit of the reaction initiation temperature range to which the feed mixture is heated due to the exothermic nature of the bromination reaction. In the case of methane, the formation of methyl bromide occurs in accordance with the following general reaction:
CH4(g)+Br2(g)→CH3Br(g)+HBr(g)
This reaction occurs with a significantly high degree of selectivity to methyl bromide. For example, in the case of bromination of methane with a methane to bromine ratio of about 4.5:1 selectivity to the mono-halogenated methyl bromide is in the range of 90 to 95%. Small amounts of dibromomethane and tribromomethane are also formed in the bromination reaction. Higher alkanes, such as ethane, propane and butane, are also readily bromoninated resulting in mono and multiple brominated species. If an alkane to bromine ratio of significantly less than about 2.5 to 1 is utilized, selectivity to methyl bromide substantially lower than 90% occurs and significant formation of undesirable carbon soot is observed. It has also been shown that other alkanes such as ethane and propane which may be present in the feed gas to the bromination reactor are readily brominated to form ethyl bromides and propyl bromides. Further, the dry bromine vapor that is feed into first reactor 30 is substantially water-free. Applicant has discovered that elimination of substantially all water vapor from the bromination step in first reactor 30 substantially eliminates the formation of unwanted carbon dioxide thereby increasing the selectivity of alkane bromination to alkyl bromides and eliminating the large amount of waste heat generated in the formation of carbon dioxide from alkanes.
The effluent that contains alkyl bromides and hydrobromic acid is withdrawn from the first reactor via line 31 and is partially cooled to a temperature in the range of about 150° C. to about 350° C. in heat exchanger 32 before flowing to a second reactor 34. In second reactor 34, the alkyl bromides are reacted exothermically at a temperature range of from about 150° C. to about 400° C., and a pressure in the range of about 1 to 30 bar, over a fixed bed 33 of crystalline alumino-silicate catalyst, preferably a zeolite catalyst, and most preferably a ZSM-5 zeolite catalyst. Although the zeolite catalyst is preferably used in the sodium or magnesium form, the zeolite may also be modified by ion exchange with other alkali metal cations, such as Li, K or Cs, with alkali-earth metal cations, such as Mg, Ca, Sr or Ba, or with transition metal cations, such as Ni, Mn, V, W. Other zeolite catalysts having varying pore sizes and acidities, which are synthesized by varying the alumina-to-silica ratio may be used in the second reactor 34 as will be evident to a skilled artisan. In this reactor, the alkyl bromides are oligimerized to produce a mixture of higher molecular weight hydrocarbon products, primarily C3, C4 and C5+ gasoline-range and heavier hydrocarbon fractions, and additional hydrobromic acid vapor.
The temperature at which the second reactor 34 is operated is an important parameter in determining the selectivity of the oligimerization reaction to various higher molecular weight liquid hydrocarbon products. It is preferred to operate second reactor 34 at a temperature within the range of about 150° C. to 400° C. Temperatures above about 300° C. in the second reactor result in increased yields of light hydrocarbons, such as undesirable methane, whereas lower temperatures increase yields of heavier molecular weight hydrocarbon products. At the low end of the temperature range, with methyl bromide reacting over ZSM-5 zeolite at temperatures as low as 150° C. significant methyl bromide conversion on the order of 20% is noted, with a high selectivity towards C5+ products. Also it is noted that methyl bromide appears to be more reactive over a lower temperature range relative to methyl chloride or other substituted methyl compounds such as methanol. Notably, in the case of the alkyl bromide reaction over the preferred zeolite ZSM-5 catalyst, cyclization reactions also occur such that the C7+ fractions are composed primarily of substituted aromatics. At increasing temperatures approaching 300° C., methyl bromide conversion increases towards 90% or greater, however selectivity towards C5+ products decreases and selectivity towards lighter products, particularly undesirable methane, increases. Surprisingly, very little ethane or C2,—C3 olefins are formed. At temperatures above about 425° C. almost complete conversion of methyl bromide to methane occurs. As a byproduct of the reaction, a small amount of carbon will build up on the catalyst over time during operation, causing a decline in catalyst activity over a range of several hundred hours, depending on the reaction conditions. It is believed that higher reaction temperatures favor the formation of carbon or coke and hence the rate of deactivation of the catalyst. Conversely, temperatures at the lower end of the range may also contribute to coking due to a reduced rate of adsorption of products. Hence, operating temperatures within the range of about 150° C. to 400° C., but preferably in the range of about 250° C. to about 350° C. in the second reactor 34 balance increased selectivity of the desired C5+ products and lower rates of deactivation due to carbon formation, against higher conversion per pass, which minimizes the quantity of catalyst, recycle rates and equipment size required.
The catalyst may be periodically regenerated in situ, by isolating reactor 34 from the normal process flow, purging with an inert gas via line 70 at a pressure in a range from about 1 to about 5 bar at an elevated temperature in the range of about 400° C. to about 600° C. to remove unreacted material adsorbed on the catalyst insofar as is practical, and then subsequently oxidizing the deposited carbon to CO2 by addition of air to reactor 34 via line 70 at a pressure in the range of about 1 bar to about 5 bar at an elevated temperature in the range of about 400° C. to about 600° C. Carbon dioxide and residual air is vented from reactor 34 via line 75 during the regeneration period.
The effluent which comprises the higher molecular weight hydrocarbon products and hydrobromic acid is withdrawn from the second reactor 34 via line 35 and is cooled to a temperature in the range of 0° C. to about 100° C. in exchanger 36 and combined with vapor effluent in line 12 from hydrocarbon stripper 47, which contains feed gas and residual hydrocarbon products stripped-out by contact with the feed gas in hydrocarbon stripper 47. The combined vapor mixture is passed to a scrubber 38 and contacted with an aqueous partially-oxidized metal bromide salt solution containing metal hydroxide and/or metal oxy-bromide species, that is transported to scrubber 38 via line 41. The preferred metal of the bromide salt is Cu(II), Zn(II) or Fe(III) as these are less expensive and readily oxidize at lower temperatures in the range of 120° C. to 180° C., allowing the use of fluorpolymer-lined equipment; although Co(II), Ni(II), Mn(II) or other transition-metals which form oxidizable bromide salts may be used in the process of the present invention. Alternatively, alkaline-earth metals which also form oxidizable bromide salts, such as Ca (II) or Mg(II) may be used. Any liquid hydrocarbon product condensed in scrubber 38 may be skimmed and withdrawn in line 37 and added to liquid hydrocarbon product exiting the product recovery unit 52 in line 54. Hydrobromic acid is dissolved in the aqueous solution and neutralized by the metal hydroxide and or metal oxy-bromide species to yield metal bromide salt in solution and water which is removed from the scrubber 38 via line 44.
The residual vapor phase containing the higher molecular weight hydrocarbon products that is removed as effluent from the scrubber 38 is forwarded via line 39 to dehydrator 50 to remove substantially all water via line 53 from the vapor stream. The water is then removed from the dehydrator 50 via line 53. The dried vapor stream containing the higher molecular weight hydrocarbon products is further passed via line 51 to product recovery unit 52 to recover propane and butane as desired, but primarily the C5+ fraction as a liquid product in line 54. Any conventional method of dehydration and liquids recovery, such as solid-bed dessicant adsorption followed by refrigerated condensation, cryogenic expansion, or circulating absorption oil, as used to process natural gas or refinery gas streams, as will be evident to a skilled artisan, may be employed in the process of the present invention. The residual vapor effluent from product recovery unit 52 is then split into a purge stream 57 which may be utilized as fuel for the process and a recycled residual vapor which is compressed via compressor 58. The recycled residual vapor discharged from compressor 58 is split into two fractions. A first fraction that is equal to at least 2.5 times the feed gas molar volume is transported via line 62 and is combined with dry liquid bromine conveyed by pump 24, heated in exchanger 26 to vaporize the bromine and fed into first reactor 30. The second fraction is drawn off of line 62 via line 63 and is regulated by control valve 60, at a rate sufficient to dilute the alkyl bromide concentration to reactor 34 and absorb the heat of reaction such that reactor 34 is maintained at the selected operating temperature, preferably in the range of about 250° C. to about 350° C. in order to optimize conversion versus selectivity and to minimize the rate of catalyst deactivation due to the deposition of carbon. Thus, the dilution provided by the recycled vapor effluent permits selectivity of bromination in the first reactor 30 to be controlled in addition to moderating the temperature in second reactor 34.
Water containing metal bromide salt in solution which is removed from scrubber 38 via line 44 is passed to hydrocarbon stripper 47 wherein residual dissolved hydrocarbons are stripped from the aqueous phase by contact with incoming feed gas transported via line 11. The stripped aqueous solution is transported from hydrocarbon stripper 47 via line 65 and is cooled to a temperature in the range of about 0° C. to about 70° C. in heat exchanger 46 and then passed to absorber 48 in which residual bromine is recovered from vent stream in line 67. The aqueous solution effluent from scrubber 48 is transported via line 49 to a heat exchanger 40 to be preheated to a temperature in the range of about 100° C. to about 600° C., and most preferably in the range of about 120° C. to about 180° C. and passed to third reactor 16. Oxygen or air is delivered via line 10 by blower or compressor 13 at a pressure in the range of about ambient to about 5 bar to bromine stripper 14 to strip residual bromine from water which is removed from stripper 14 in line 64 and is combined with water stream 53 from dehydrator 50 to form water effluent stream in line 56 which is removed from the process. The oxygen or air leaving bromine stripper 14 is fed via line 15 to reactor 16 which operates at a pressure in the range of about ambient to about 5 bar and at a temperature in the range of about 100° C. to about 600° C., but most preferably in the range of about 120° C. to about 180° C. so as to oxidize an aqueous metal bromide salt solution to yield elemental bromine and metal hydroxide and or metal oxy-bromide species. As stated above, although Co(II), Ni(II), Mn(II) or other transition-metals which form oxidizable bromide salts can be used, the preferred metal of the bromide salt is Cu(II), Zn(II) or Fe(III) as these are less expensive and readily oxidize at lower temperatures in the range of about 120° C. to about 180° C., allowing the use of fluorpolymer-lined equipment. Alternatively, alkaline-earth metals which also form oxidizable bromide salts, such as Ca (II) or Mg(II) could be used.
Hydrobromic acid reacts with the metal hydroxide or metal oxy-bromide species so formed to once again yield the metal bromide salt and water. Heat exchanger 18 in reactor 16 supplies heat to vaporize water and bromine. Thus, the overall reactions result in the net oxidation of hydrobromic acid produced in first reactor 30 and second reactor 34 to elemental bromine and steam in the liquid phase catalyzed by the metal bromide/metal hydroxide operating in a catalytic cycle. In the case of the metal bromide being Cu(II)Br2 the reactions are believed to be:
4Cu(+2a)+8Br(−a)+3H2O+3/2O2(g)=3Br2(g)+CuBr2.3Cu(OH)2
6HBr(g)+H2O=6H(+a)+6Br(−a)+H2O
6H(+a)+6Br(−a)+CuBr2.3Cu(OH)2=4Cu(+2a)+8Br(−a)+6H2O
The elemental bromine and water and any residual oxygen or nitrogen (if air is utilized as the oxidant) leaving as vapor from the outlet of third reactor 16 via line 19, are cooled in condenser 20 at a temperature in the range of about 0° C. to about 70° C. and a pressure in the range of about ambient to 5 bar to condense the bromine and water and passed to three-phase separator 22. In three-phase separator 22, since liquid water has a limited solubility for bromine, on the order of about 3% by weight, any additional bromine which is condensed forms a separate, denser liquid bromine phase. The liquid bromine phase, however, has a notably lower solubility for water, on the order of less than 0.1%. Thus a substantially dry bromine vapor can be easily obtained by condensing liquid bromine and water, decanting water by simple physical separation and subsequently re-vaporizing liquid bromine.
Liquid bromine is pumped in line 25 from three-phase separator 22 via pump 24 to a pressure sufficient to mix with vapor stream 62. Thus bromine is recovered and recycled within the process. The residual oxygen or nitrogen and any residual bromine vapor which is not condensed exits three-phase separator 22 and is passed via line 23 to bromine scrubber 48, wherein residual bromine is recovered by solution into and by reaction with reduced metal bromides in the aqueous metal bromide solution stream 65. Water is removed from separator 22 via line 27 and introduced into stripper 14.
In another embodiment of the invention, referring to
CH4(g)+Br2(g)→CH3Br(g)+HBr(g)
This reaction occurs with a significantly high degree of selectivity to methyl bromide. For example, in the case of bromine reacting with a molar excess of methane at a methane to bromine ratio of 4.5:1, selectivity to the mono-halogenated methyl bromide is in the range of 90 to 95%. Small amounts of dibromomethane and tribromomethane are also formed in the bromination reaction. Higher alkanes, such as ethane, propane and butane, are also readily bromoninated resulting in mono and multiple brominated species. If an alkane to bromine ratio of significantly less than 2.5 to 1 is utilized, selectivity to methyl bromide substantially lower than 90% occurs and significant formation of undesirable carbon soot is observed. It has also been shown that other alkanes such as ethane and propane which may be present in the feed gas to the bromination are readily brominated to form ethyl bromides and propyl bromides. Further, the dry bromine vapor that is feed into first reactor 130 is substantially water-free. Applicant has discovered that elimination of substantially all water vapor from the bromination step in first reactor 130 substantially eliminates the formation of unwanted carbon dioxide thereby increasing the selectivity of alkane bromination to alkyl bromides and eliminating the large amount of waste heat generated in the formation of carbon dioxide from alkanes.
The effluent that contains alkyl bromides and hydrobromic acid is withdrawn from the first reactor 130 via line 131 and is partially cooled to a temperature in the range of about 150° C. to 350° C. in heat exchanger 132 before flowing to a second reactor 134. In second reactor 134, the alkyl bromides are reacted exothermically at a temperature range of from about 150° C. to about 400° C., and a pressure in the range of about 1 bar to 30 bar, over a fixed bed of crystalline alumino-silicate catalyst, preferably a zeolite catalyst, and most preferably a ZSM-5 zeolite catalyst. Although the zeolite catalyst is preferably used in the sodium or magnesium form, the zeolite may also be modified by ion exchange with other alkali metal cations, such as Li, K or Cs, with alkali-earth metal cations, such as Mg, Ca, Sr or Ba, or with transition metal cations, such as Ni, Mn, V, W. Other zeolite catalysts having varying pore sizes and acidities, which are synthesized by varying the alumina-to-silica ratio may be used in the second reactor 134 as will be evident to a skilled artisan. In this reactor, the alkyl bromides are oligimerized to produce a mixture of higher molecular weight hydrocarbon products and additional hydrobromic acid vapor.
The temperature at which the second reactor 134 is operated is an important parameter in determining the selectivity of the oligimerization reaction to various higher molecular weight liquid hydrocarbon products. It is preferred to operate second reactor 134 at a temperature within the range of about 150° to 400°, but more preferably within the range of about 250 C to 350 C. Temperatures above about 300° C. in the second reactor result in increased yields of light hydrocarbons, such as undesirable methane, whereas lower temperatures increase yields of heavier molecular weight hydrocarbon products. At the low end of the temperature range, methyl bromide reacting over ZSM-5 zeolite at temperatures as low as 150° C. significant methyl bromide conversion on the order of 20% is noted, with a high selectivity towards C5+ products. Notably, in the case of alkyl bromides reacting over the preferred ZSM-5 zeolite catalyst, cyclization reactions occur such that the C7+ fractions produced contain a high percentage of substituted aromatics. At increasing temperatures approaching 300° C., methyl bromide conversion increases towards 90% or greater, however selectivity towards C5+ products decreases and selectivity towards lighter products, particularly undesirable methane, increases. Surprisingly, very little ethane or C2-C4 olefin compounds are produced. At temperatures above about 425° C. almost complete conversion of methyl bromide to methane occurs. As a byproduct of the reaction, a small amount of carbon will build up on the catalyst over time during operation, causing a decline in catalyst activity over a range of several hundred hours, depending on the reaction conditions. It is believed that higher reaction temperatures favor the formation of carbon and hence rate of deactivation of the catalyst. Conversely, operation at the lower end of the temperature range may promote coking, likely to the reduced rate of desorption of hydrocarbon products. Hence, operating temperatures within the range of about 150° C. to 400° C. but more preferably in the range of about 250° C. to 350° C. in the second reactor 134 balance increased selectivity towards the desired products and lower rates of deactivation due to carbon formation, against higher conversion per pass, which minimizes the quantity of catalyst, recycle rates and equipment size required.
The catalyst may be periodically regenerated in situ, by isolating reactor 134 from the normal process flow, purging with an inert gas via line 170 at a pressure in the range of about 1 bar to about 5 bar and an elevated temperature in the range of 400° C. to 600° C. to remove unreacted material adsorbed on the catalyst insofar as is practical, and then subsequently oxidizing the deposited carbon to CO2 by addition of air via line 170 to reactor 134 at a pressure in the range of about 1 bar to about 5 bar and an elevated temperature in the range of 400° C. to 600° C. Carbon dioxide and residual air are vented from reactor 134 via line 175 during the regeneration period.
The effluent which comprises the higher molecular weight hydrocarbon products and hydrobromic acid is withdrawn from the second reactor 134 via line 135, cooled to a temperature in the range of 0° C. to 100° C. in exchanger 136, and combined with vapor effluent in line 112 from hydrocarbon stripper 147. The mixture is then passed to a scrubber 138 and contacted with a stripped, recirculated water that is transported to scrubber 138 in line 164 by any suitable means, such as pump 143, and is cooled to a temperature in the range of 0° C. to 50° C. in heat exchanger 155. Any liquid hydrocarbon product condensed in scrubber 138 may be skimmed and withdrawn as stream 137 and added to liquid hydrocarbon product 154. Hydrobromic acid is dissolved in scrubber 138 in the aqueous solution which is removed from the scrubber 138 via line 144, and passed to hydrocarbon stripper 147 wherein residual hydrocarbons dissolved in the aqueous solution are stripped-out by contact with feed gas 111. The stripped aqueous phase effluent from hydrocarbon stripper 147 is cooled to a temperature in the range of 0° C. to 50° C. in heat exchanger 146 and then passed via line 165 to absorber 148 in which residual bromine is recovered from vent stream 167.
The residual vapor phase containing the higher molecular weight hydrocarbon products is removed as effluent from the scrubber 138 and forwarded to dehydrator 150 to remove substantially all water from the gas stream. The water is then removed from the dehydrator 150 via line 153. The dried gas stream containing the higher molecular weight hydrocarbon products is further passed via line 151 to product recovery unit 152 to recover C3 and C4 as desired, but primarily the C5+ fraction as a liquid product in line 154. Any conventional method of dehydration and liquids recovery such as solid-bed dessicant adsorption followed by, for example, refrigerated condensation, cryogenic expansion, or circulating absorption oil, as used to process natural gas or refinery gas streams, as known to a skilled artisan, may be employed in the implementation of this invention. The residual vapor effluent from product recovery unit 152 is then split into a purge stream 157 that may be utilized as fuel for the process and a recycled residual vapor which is compressed via compressor 158. The recycled residual vapor discharged from compressor 158 is split into two fractions. A first fraction that is equal to at least 2.5 times the feed gas volume is transported via line 162, combined with the liquid bromine conveyed in line 125 and passed to heat exchanger 126 wherein the liquid bromine is vaporized and fed into first reactor 130. The second fraction which is drawn off line 162 via line 163 and is regulated by control valve 160, at a rate sufficient to dilute the alkyl bromide concentration to reactor 134 and absorb the heat of reaction such that reactor 134 is maintained at the selected operating temperature, preferably in the range of 250° C. to 350° C. in order to optimize conversion vs. selectivity and to minimize the rate of catalyst deactivation due to the deposition of carbon. Thus, the dilution provided by the recycled vapor effluent permits selectivity of bromination in the first reactor 130 to be controlled in addition to moderating the temperature in second reactor 134.
Oxygen or O2-enriched air 110 is delivered via blower or compressor 113 at a pressure in the range of about ambient to about 5 bar to bromine stripper 114 to strip residual bromine from water which leaves stripper 114 via line 164 and is divided into two portions. The first portion of the stripped water is recycled via line 164, cooled in heat exchanger 155 to a temperature in the range of about 20° C. to about 50° C., and maintained at a pressure sufficient to enter scrubber 138 by any suitable means, such as pump 143. The portion of water that is recycled is selected such that the hydrobromic acid solution effluent removed from scrubber 138 via line 144 has a concentration in the range from about 10% to about 50% by weight hydrobromic acid, but more preferably in the range of about 30% to about 48% by weight to minimize the amount of water which must be vaporized in exchanger 141 and preheater 119. A second portion of water from stripper 114 is removed from line 164 and the process via line 156.
The dissolved hydrobromic acid that is contained in the aqueous solution effluent from scrubber 148 is transported via line 149 and is combined with the oxygen or O2-enriched air leaving bromine stripper 114 in line 115. The combined aqueous solution effluent and oxygen or O2-enriched air is passed to a first side of heat exchanger 141 and through preheater 119 wherein the mixture is preheated to a temperature in the range of about 100° C. to about 600° C. and most preferably in the range of about 120° C. to about 180° C. and passed to third reactor 117 that contains a metal bromide salt. The preferred metal of the bromide salt is Cu(II), Zn(II) or Fe(III) although Co(II), Ni(II), Mn(II) or other transition-metals which form oxidizable bromide salts can be used. Alternatively, alkaline-earth metals which also form oxidizable bromide salts, such as Ca(II) or Mg(II) could be used. The metal bromide salt in the oxidation reactor 117 can be utilized as a concentrated aqueous solution or preferably, the concentrated aqueous salt may be imbibed into a porous, high surface area, acid resistant inert support such as a silica gel. The oxidation reactor 117 operates at a pressure in the range of about ambient to about 5 bar and at a temperature in the range of about 100° C. to 600° C., but most preferably in the range of about 120° C. to 180° C.; therein, the metal bromide is oxidized by oxygen, yielding elemental bromine and metal hydroxide or metal oxy-bromide species or, metal oxides in the case of the supported metal bromide salt operated at higher temperatures and lower pressures at which water may primarily exist as a vapor. In either case, the hydrobromic acid reacts with the metal hydroxide, metal oxy-bromide or metal oxide species and is neutralized, restoring the metal bromide salt and yielding water. Thus, the overall reaction results in the net oxidation of hydrobromic acid produced in first reactor 130 and second reactor 134 to elemental bromine and steam, catalyzed by the metal bromide/metal hydroxide or metal oxide operating in a catalytic cycle. In the case of the metal bromide being Cu(II)Br2 in an aqueous solution and operated in a pressure and temperature range in which water may exist as a liquid the reactions are believed to be:
4Cu(+2a)+8Br(−a)+3H2O+3/2O2(g)=3Br2(g)+CuBr2.3Cu(OH)2
6HBr(g)+H2O=6H(+a)+6Br(−a)+H2O
6H(+a)+6Br(−a)+CuBr2.3Cu(OH)2=4Cu(+2a)+8Br(−a)+6H2O
In the case of the metal bromide being Cu(II)Br2 supported on an inert support and operated at higher temperature and lower pressure conditions at which water primarily exists as a vapor, the reactions are believed to be:
Cu(II)Br2+1/2O2(g)=Br2(g)+Cu(II)O
2HBr(g)+Cu(II)O=Cu(II)Br2+H2O(g)
The elemental bromine and water and any residual oxygen or nitrogen (if enriched air is utilized as the oxidant) leaving as vapor from the outlet of third reactor 117, are cooled in the second side of exchanger 141 and condenser 120 to a temperature in the range of about 0° C. to about 70° C. wherein the bromine and water are condensed and passed to three-phase separator 122. In three-phase separator 122, since liquid water has a limited solubility for bromine, on the order of about 3% by weight, any additional bromine which is condensed forms a separate, denser liquid bromine phase. The liquid bromine phase, however, has a notably lower solubility for water, on the order of less than 0.1%. Thus, a substantially dry bromine vapor can be easily obtained by condensing liquid bromine and water, decanting water by simple physical separation and subsequently re-vaporizing liquid bromine.
Liquid bromine is pumped from three-phase separator 122 via pump 124 to a pressure sufficient to mix with vapor stream 162. Thus the bromine is recovered and recycled within the process. The residual enriched air or oxygen and any bromine vapor which is not condensed exits three-phase separator 122 and is passed via line 123 to bromine scrubber 148, wherein residual bromine is recovered by dissolution into hydrobromic acid solution stream conveyed to scrubber 148 via line 165. Water is removed from the three-phase separator 122 via line 129 and passed to stripper 114.
The following examples demonstrate the practice and utility of the present invention, but are not to be construed as limiting the scope thereof.
Various mixtures of dry bromine and methane are reacted homogeneously at temperatures in the range of 459° C. to 491° C. at a Gas Hourly Space Velocity (GHSV which is defined as the gas flow rate in standard liters per hour divided by the gross reactor catalyst-bed volume, including catalyst-bed porosity, in liters) of approximately 7200 hr−1. The results of this example indicate that for molar ratios of methane to bromine greater than 4.5:1 selectivity to methyl bromide is in the range of 90 to 95%, with near-complete conversion of bromine.
Methyl bromide is reacted over a ZSM-5 zeolite catalyst at a Gas Hourly Space Velocity (GHSV) of approximately 94 hr−1 over a range of temperatures from about 100° C. to about 460° C. at approximately 2 bar pressure. As illustrated in
Methyl bromide, hydrogen bromide and methane are reacted over a ZSM-5 zeolite catalyst at approximately 2 bar pressure at about 250° C. and also at about 260° C. at a GHSV of approximately 76 hr−1. Comparison tests utilizing a mixture of only methyl bromide and methane without hydrogen bromide over the same ZSM-5 catalyst at approximately the same pressure at about 250° C. and at about 260° C. at a GHSV of approximately 73 hr−1 were also run.
Methyl bromide is reacted over a ZSM-5 zeolite catalyst at 230° C. Dibromomethane is added to the reactor.
A mixture of 12.1 mol % methyl bromide and 2.8 mol % propyl bromide in methane are reacted over a ZSM-5 zeolite catalyst at 295 C and a GHSV of approximately 260 hr−1. A methyl bromide conversion of approximately 86% and a propyl bromide conversion of approximately 98% is observed.
Thus, in accordance with all embodiments of the present invention, the metal bromide/metal hydroxide, metal oxy-bromide or metal oxide operates in a catalytic cycle allowing bromine to be easily recycled within the process. The metal bromide is readily oxidized by oxygen or air either in the aqueous phase or the vapor phase at temperatures in the range of about 100° C. to about 600° C. and most preferably in the range of about 120° C. to 180° C. to yield elemental bromine vapor and metal hydroxide, metal oxy-bromide or metal oxide. Operation at temperatures below about 180° C. is advantageous, thereby allowing the use of low-cost corrosion-resistant fluoropolymer-lined equipment. Hydrobromic acid is neutralized by reaction with the metal hydroxide or metal oxide yielding steam and the metal bromide.
The elemental bromine vapor and steam are condensed and easily separated in the liquid phase by simple physical separation, yielding substantially dry bromine. The absence of significant water allows selective bromination of alkanes, without production of CO2 and the subsequent efficient and selective oligimerization and cyclization reactions of alkyl bromides to primarily propane and heavier products, the C5+ fraction of which contains substantial branched alkanes and substituted aromatics. Byproduct hydrobromic acid vapor from the bromination and oligimerization reaction are readily dissolved into an aqueous phase and neutralized by the metal hydroxide or metal oxide species resulting from oxidation of the metal bromide.
The process of the present invention is less expensive than conventional processes since it operates at low pressures in the range of about 1 bar to about 30 bar and at relatively low temperatures in the range of about 20° C. to about 600° C. for the gas phase, and preferably about 20° C. to about 180° C. for the liquid phase. These operating conditions permit the use of less expensive equipment of relatively simple design that are constructed from readily available metal alloys for the gas phase and polymer-lined vessels, piping and pumps for the liquid phase. The process of the present invention is also more efficient because less energy is required for operation and the production of excessive carbon dioxide as an unwanted byproduct is minimized. The process is capable of directly producing a mixed hydrocarbon product containing various molecular-weight components in the liquefied petroleum gas (LPG) and motor gasoline fuels range that have substantial aromatic content thereby significantly increasing the octane value of the gasoline-range fuel components.
While the foregoing preferred embodiments of the invention have been described and shown, it is understood that the alternatives and modifications, such as those suggested and others, may be made thereto and fall within the scope of the invention.
This application is a continuation of U.S. patent application Ser. No. 10/826,885, filed on Apr. 16, 2004, now U.S. Pat. No. 7,244,867 and titled “Process for Converting Gaseous Alkanes to Liquid Hydrocarbons”.
Number | Name | Date | Kind |
---|---|---|---|
2168260 | Heisel et al. | Aug 1939 | A |
2246082 | Vaughan et al. | Jun 1941 | A |
2488083 | Gorin et al. | Nov 1949 | A |
2536457 | Mugdan | Jan 1951 | A |
2677598 | Crummett et al. | May 1954 | A |
2941014 | Rothweiler et al. | Jun 1960 | A |
3076784 | Schulte-Huermann et al. | Feb 1963 | A |
3172915 | Borkowski et al. | Mar 1965 | A |
3246043 | Rosset et al. | Apr 1966 | A |
3273964 | Rosset | Sep 1966 | A |
3294846 | Livak et al. | Dec 1966 | A |
3310380 | Lester | Mar 1967 | A |
3346340 | Louvar et al. | Oct 1967 | A |
3353916 | Lester | Nov 1967 | A |
3353919 | Stockman | Nov 1967 | A |
3496242 | Berkowitz et al. | Feb 1970 | A |
3562321 | Borkowski et al. | Feb 1971 | A |
3598876 | Bloch | Aug 1971 | A |
3657367 | Blake et al. | Apr 1972 | A |
3670037 | Dugan | Jun 1972 | A |
3673264 | Kuhn | Jun 1972 | A |
3679758 | Schneider | Jul 1972 | A |
3702886 | Argauer et al. | Nov 1972 | A |
3705196 | Turner | Dec 1972 | A |
3799997 | Schmerling | Mar 1974 | A |
3865886 | Schindler et al. | Feb 1975 | A |
3876715 | McNulty et al. | Apr 1975 | A |
3879473 | Stapp | Apr 1975 | A |
3879480 | Riegel et al. | Apr 1975 | A |
3883651 | Woitun et al. | May 1975 | A |
3886287 | Kobayashi et al. | May 1975 | A |
3894103 | Chang et al. | Jul 1975 | A |
3894104 | Chang et al. | Jul 1975 | A |
3894105 | Chang et al. | Jul 1975 | A |
3894107 | Butter et al. | Jul 1975 | A |
3907917 | Forth | Sep 1975 | A |
3919336 | Kurtz | Nov 1975 | A |
3920764 | Riegel et al. | Nov 1975 | A |
3923913 | Antonini et al. | Dec 1975 | A |
3928483 | Chang et al. | Dec 1975 | A |
3965205 | Garwood et al. | Jun 1976 | A |
3974062 | Owen et al. | Aug 1976 | A |
3987119 | Kurtz et al. | Oct 1976 | A |
3992466 | Plank et al. | Nov 1976 | A |
4006169 | Anderson et al. | Feb 1977 | A |
4011278 | Plank et al. | Mar 1977 | A |
4025571 | Lago | May 1977 | A |
4025572 | Lago | May 1977 | A |
4025575 | Chang et al. | May 1977 | A |
4025576 | Chang et al. | May 1977 | A |
4035285 | Owen et al. | Jul 1977 | A |
4035430 | Dwyer et al. | Jul 1977 | A |
4039600 | Chang | Aug 1977 | A |
4044061 | Chang et al. | Aug 1977 | A |
4046825 | Owen et al. | Sep 1977 | A |
4049734 | Garwood et al. | Sep 1977 | A |
4052471 | Pearsall | Oct 1977 | A |
4052472 | Givens et al. | Oct 1977 | A |
4058576 | Chang et al. | Nov 1977 | A |
4060568 | Rodewald | Nov 1977 | A |
4071753 | Fulenwider et al. | Jan 1978 | A |
4072733 | Hargis et al. | Feb 1978 | A |
4087475 | Jordan | May 1978 | A |
4088706 | Kaeding | May 1978 | A |
4092368 | Smith | May 1978 | A |
4105755 | Darnell et al. | Aug 1978 | A |
4110180 | Nidola et al. | Aug 1978 | A |
4117251 | Kaufhold et al. | Sep 1978 | A |
4129604 | Tsao | Dec 1978 | A |
4133838 | Pearson | Jan 1979 | A |
4133966 | Pretzer et al. | Jan 1979 | A |
4138440 | Chang et al. | Feb 1979 | A |
4143084 | Kaeding et al. | Mar 1979 | A |
4156698 | Dwyer et al. | May 1979 | A |
4169862 | Eden | Oct 1979 | A |
4172099 | Severino | Oct 1979 | A |
4187255 | Dodd | Feb 1980 | A |
4191618 | Coker et al. | Mar 1980 | A |
4194990 | Pieters et al. | Mar 1980 | A |
4197420 | Ferraris et al. | Apr 1980 | A |
4219680 | Konig et al. | Aug 1980 | A |
4249031 | Drent et al. | Feb 1981 | A |
4252687 | Dale et al. | Feb 1981 | A |
4270929 | Dang Vu et al. | Jun 1981 | A |
4272338 | Lynch et al. | Jun 1981 | A |
4282159 | Davidson et al. | Aug 1981 | A |
4300005 | Li | Nov 1981 | A |
4300009 | Haag et al. | Nov 1981 | A |
4301253 | Warren | Nov 1981 | A |
4302619 | Gross et al. | Nov 1981 | A |
4307261 | Beard, Jr. et al. | Dec 1981 | A |
4308403 | Knifton | Dec 1981 | A |
4311865 | Chen et al. | Jan 1982 | A |
4317800 | Sloterdijk et al. | Mar 1982 | A |
4317934 | Seemuth | Mar 1982 | A |
4317943 | Knifton | Mar 1982 | A |
4320241 | Frankiewicz | Mar 1982 | A |
4333852 | Warren | Jun 1982 | A |
4347391 | Campbell | Aug 1982 | A |
4350511 | Holmes et al. | Sep 1982 | A |
4371716 | Paxson et al. | Feb 1983 | A |
4373109 | Olah | Feb 1983 | A |
4376019 | Gamlen et al. | Mar 1983 | A |
4380682 | Leitert et al. | Apr 1983 | A |
4384159 | Diesen | May 1983 | A |
4389391 | Dunn, Jr. | Jun 1983 | A |
4410714 | Apanel | Oct 1983 | A |
4412086 | Beard, Jr. et al. | Oct 1983 | A |
4418236 | Cornelius et al. | Nov 1983 | A |
4431856 | Daviduk et al. | Feb 1984 | A |
4433189 | Young | Feb 1984 | A |
4433192 | Olah | Feb 1984 | A |
4439409 | Puppe et al. | Mar 1984 | A |
4440871 | Lok et al. | Apr 1984 | A |
4443620 | Gelbein et al. | Apr 1984 | A |
4462814 | Holmes et al. | Jul 1984 | A |
4465884 | Degnan et al. | Aug 1984 | A |
4465893 | Olah | Aug 1984 | A |
4467130 | Olah | Aug 1984 | A |
4467133 | Chang et al. | Aug 1984 | A |
4489210 | Judat et al. | Dec 1984 | A |
4489211 | Ogura et al. | Dec 1984 | A |
4492657 | Heiss | Jan 1985 | A |
4496752 | Gelbein et al. | Jan 1985 | A |
4497967 | Wan | Feb 1985 | A |
4499314 | Seddon et al. | Feb 1985 | A |
4506105 | Kaufhold | Mar 1985 | A |
4509955 | Hayashi | Apr 1985 | A |
4513092 | Chu et al. | Apr 1985 | A |
4513164 | Olah | Apr 1985 | A |
4523040 | Olah | Jun 1985 | A |
4524227 | Fowles et al. | Jun 1985 | A |
4524228 | Fowles et al. | Jun 1985 | A |
4524231 | Fowles et al. | Jun 1985 | A |
4538014 | Miale et al. | Aug 1985 | A |
4538015 | Miale et al. | Aug 1985 | A |
4540826 | Banasiak et al. | Sep 1985 | A |
4543434 | Chang | Sep 1985 | A |
4544781 | Chao et al. | Oct 1985 | A |
4547612 | Tabak | Oct 1985 | A |
4550217 | Graziani et al. | Oct 1985 | A |
4550218 | Chu | Oct 1985 | A |
4568660 | Klosiewicz | Feb 1986 | A |
4579977 | Drake | Apr 1986 | A |
4579992 | Kaufhold et al. | Apr 1986 | A |
4579996 | Font Freide et al. | Apr 1986 | A |
4587375 | Debras et al. | May 1986 | A |
4588835 | Torii et al. | May 1986 | A |
4590310 | Townsend et al. | May 1986 | A |
4599474 | Devries et al. | Jul 1986 | A |
4605796 | Isogai et al. | Aug 1986 | A |
4605803 | Chang et al. | Aug 1986 | A |
4621161 | Shihabi | Nov 1986 | A |
4621164 | Chang et al. | Nov 1986 | A |
4633027 | Owen et al. | Dec 1986 | A |
4634800 | Withers, Jr. et al. | Jan 1987 | A |
4642403 | Hyde et al. | Feb 1987 | A |
4642404 | Shihabi | Feb 1987 | A |
4652688 | Brophy et al. | Mar 1987 | A |
4654449 | Chang et al. | Mar 1987 | A |
4655893 | Beale | Apr 1987 | A |
4658073 | Tabak | Apr 1987 | A |
4658077 | Kolts et al. | Apr 1987 | A |
4665259 | Brazdil et al. | May 1987 | A |
4665267 | Barri | May 1987 | A |
4665270 | Brophy et al. | May 1987 | A |
4675410 | Feitler et al. | Jun 1987 | A |
4690903 | Chen et al. | Sep 1987 | A |
4695663 | Hall et al. | Sep 1987 | A |
4696985 | Martin | Sep 1987 | A |
4704488 | Devries et al. | Nov 1987 | A |
4704493 | Devires et al. | Nov 1987 | A |
4709108 | Devries et al. | Nov 1987 | A |
4720600 | Beech, Jr. et al. | Jan 1988 | A |
4720602 | Chu | Jan 1988 | A |
4724275 | Hinnenkamp et al. | Feb 1988 | A |
4735747 | Ollivier et al. | Apr 1988 | A |
4737594 | Olah | Apr 1988 | A |
4748013 | Saito et al. | May 1988 | A |
4769504 | Noceti et al. | Sep 1988 | A |
4774216 | Kolts et al. | Sep 1988 | A |
4775462 | Imai et al. | Oct 1988 | A |
4777321 | Harandi et al. | Oct 1988 | A |
4781733 | Babcock et al. | Nov 1988 | A |
4783566 | Kocal et al. | Nov 1988 | A |
4788369 | Marsh et al. | Nov 1988 | A |
4788377 | Chang et al. | Nov 1988 | A |
4792642 | Rule et al. | Dec 1988 | A |
4795732 | Barri | Jan 1989 | A |
4795737 | Rule et al. | Jan 1989 | A |
4795843 | Imai et al. | Jan 1989 | A |
4795848 | Teller et al. | Jan 1989 | A |
4804797 | Minet et al. | Feb 1989 | A |
4804800 | Bortinger et al. | Feb 1989 | A |
4808763 | Shum | Feb 1989 | A |
4814527 | Diesen | Mar 1989 | A |
4814532 | Yoshida et al. | Mar 1989 | A |
4814535 | Yurchak | Mar 1989 | A |
4814536 | Yuchak | Mar 1989 | A |
4849562 | Buhs et al. | Jul 1989 | A |
4849573 | Kaefing | Jul 1989 | A |
4851602 | Harandi et al. | Jul 1989 | A |
4851606 | Ragonese et al. | Jul 1989 | A |
4886925 | Harandi | Dec 1989 | A |
4886932 | Leyshon | Dec 1989 | A |
4891463 | Chu | Jan 1990 | A |
4895995 | James, Jr. et al. | Jan 1990 | A |
4899000 | Stauffer | Feb 1990 | A |
4899001 | Kalnes et al. | Feb 1990 | A |
4899002 | Harandi et al. | Feb 1990 | A |
4902842 | Kalnes et al. | Feb 1990 | A |
4925995 | Robschlager | May 1990 | A |
4929781 | James, Jr. et al. | May 1990 | A |
4939310 | Wade | Jul 1990 | A |
4939311 | Washecheck et al. | Jul 1990 | A |
4939314 | Harandi et al. | Jul 1990 | A |
4945175 | Hobbs et al. | Jul 1990 | A |
4950811 | Doussain et al. | Aug 1990 | A |
4950822 | Dileo et al. | Aug 1990 | A |
4956521 | Volles | Sep 1990 | A |
4962252 | Wade | Oct 1990 | A |
4973776 | Allenger et al. | Nov 1990 | A |
4973786 | Karra | Nov 1990 | A |
4982024 | Lin et al. | Jan 1991 | A |
4982041 | Campbell | Jan 1991 | A |
4988660 | Campbell | Jan 1991 | A |
4990696 | Stauffer | Feb 1991 | A |
4990711 | Chen et al. | Feb 1991 | A |
5001293 | Nubel et al. | Mar 1991 | A |
5004847 | Beaver et al. | Apr 1991 | A |
5013424 | James, Jr. et al. | May 1991 | A |
5013793 | Wang et al. | May 1991 | A |
5019652 | Taylor et al. | May 1991 | A |
5026934 | Bains et al. | Jun 1991 | A |
5026937 | Bricker | Jun 1991 | A |
5026944 | Allenger et al. | Jun 1991 | A |
5034566 | Ishino et al. | Jul 1991 | A |
5043502 | Martindale et al. | Aug 1991 | A |
5055235 | Brackenridge et al. | Oct 1991 | A |
5055625 | Neidiffer et al. | Oct 1991 | A |
5055633 | Volles | Oct 1991 | A |
5055634 | Volles | Oct 1991 | A |
5059744 | Harandi et al. | Oct 1991 | A |
5068478 | Miller et al. | Nov 1991 | A |
5071449 | Sircar | Dec 1991 | A |
5071815 | Wallace et al. | Dec 1991 | A |
5073656 | Chafin et al. | Dec 1991 | A |
5073657 | Warren | Dec 1991 | A |
5082473 | Keefer | Jan 1992 | A |
5082816 | Teller et al. | Jan 1992 | A |
5085674 | Leavitt | Feb 1992 | A |
5087779 | Nubel et al. | Feb 1992 | A |
5087786 | Nubel et al. | Feb 1992 | A |
5087787 | Kimble et al. | Feb 1992 | A |
5093533 | Wilson | Mar 1992 | A |
5093542 | Gaffney | Mar 1992 | A |
5096469 | Keefer | Mar 1992 | A |
5097083 | Stauffer | Mar 1992 | A |
5099084 | Stauffer | Mar 1992 | A |
5105045 | Kimble et al. | Apr 1992 | A |
5105046 | Washecheck | Apr 1992 | A |
5107032 | Erb et al. | Apr 1992 | A |
5107051 | Pannell | Apr 1992 | A |
5107061 | Ou et al. | Apr 1992 | A |
5108579 | Casci | Apr 1992 | A |
5118899 | Kimble et al. | Jun 1992 | A |
5120332 | Wells | Jun 1992 | A |
5132343 | Zwecker et al. | Jul 1992 | A |
5138112 | Gosling et al. | Aug 1992 | A |
5139991 | Taylor et al. | Aug 1992 | A |
5146027 | Gaffney | Sep 1992 | A |
5157189 | Karra | Oct 1992 | A |
5160502 | Kimble et al. | Nov 1992 | A |
5166452 | Gradl et al. | Nov 1992 | A |
5175382 | Hebgen et al. | Dec 1992 | A |
5178748 | Casci et al. | Jan 1993 | A |
5185479 | Stauffer | Feb 1993 | A |
5188725 | Harandi | Feb 1993 | A |
5191142 | Marshall et al. | Mar 1993 | A |
5194244 | Brownscombe et al. | Mar 1993 | A |
5202506 | Kirchner et al. | Apr 1993 | A |
5202511 | Salinas, III et al. | Apr 1993 | A |
5208402 | Wilson | May 1993 | A |
5210357 | Kolts et al. | May 1993 | A |
5215648 | Zones et al. | Jun 1993 | A |
5223471 | Washecheck | Jun 1993 | A |
5228888 | Gmelin et al. | Jul 1993 | A |
5233113 | Periana et al. | Aug 1993 | A |
5237115 | Makovec et al. | Aug 1993 | A |
5243098 | Miller et al. | Sep 1993 | A |
5243114 | Johnson et al. | Sep 1993 | A |
5245109 | Kaminsky et al. | Sep 1993 | A |
5254772 | Dukat et al. | Oct 1993 | A |
5254790 | Thomas et al. | Oct 1993 | A |
5264635 | Le et al. | Nov 1993 | A |
5268518 | West et al. | Dec 1993 | A |
5276226 | Horvath et al. | Jan 1994 | A |
5276240 | Timmons et al. | Jan 1994 | A |
5276242 | Wu | Jan 1994 | A |
5284990 | Peterson et al. | Feb 1994 | A |
5300126 | Brown et al. | Apr 1994 | A |
5306855 | Periana et al. | Apr 1994 | A |
5316995 | Kaminsky et al. | May 1994 | A |
5319132 | Ozawa et al. | Jun 1994 | A |
5334777 | Miller et al. | Aug 1994 | A |
5345021 | Casci et al. | Sep 1994 | A |
5354916 | Horvath et al. | Oct 1994 | A |
5354931 | Jan et al. | Oct 1994 | A |
5366949 | Schubert | Nov 1994 | A |
5371313 | Ostrowicki | Dec 1994 | A |
5382704 | Krespan et al. | Jan 1995 | A |
5382743 | Beech, Jr. et al. | Jan 1995 | A |
5382744 | Abbott et al. | Jan 1995 | A |
5385650 | Howarth et al. | Jan 1995 | A |
5385718 | Casci et al. | Jan 1995 | A |
5395981 | Marker | Mar 1995 | A |
5399258 | Fletcher et al. | Mar 1995 | A |
5401890 | Parks | Mar 1995 | A |
5401894 | Brasier et al. | Mar 1995 | A |
5406017 | Withers, Jr. | Apr 1995 | A |
5414173 | Garces et al. | May 1995 | A |
5430210 | Grasselli et al. | Jul 1995 | A |
5430214 | Smith et al. | Jul 1995 | A |
5430219 | Sanfilippo et al. | Jul 1995 | A |
5436378 | Masini et al. | Jul 1995 | A |
5444168 | Brown | Aug 1995 | A |
5446234 | Casci et al. | Aug 1995 | A |
5453557 | Harley et al. | Sep 1995 | A |
5456822 | Marcilly et al. | Oct 1995 | A |
5457255 | Kumata et al. | Oct 1995 | A |
5464799 | Casci et al. | Nov 1995 | A |
5465699 | Voigt | Nov 1995 | A |
5470377 | Whitlock | Nov 1995 | A |
5480629 | Thompson et al. | Jan 1996 | A |
5486627 | Quarderer, Jr. et al. | Jan 1996 | A |
5489719 | Le et al. | Feb 1996 | A |
5489727 | Randolph et al. | Feb 1996 | A |
5500297 | Thompson et al. | Mar 1996 | A |
5510525 | Sen et al. | Apr 1996 | A |
5523503 | Funk et al. | Jun 1996 | A |
5525230 | Wrigley et al. | Jun 1996 | A |
5538540 | Whitlock | Jul 1996 | A |
5563313 | Chung et al. | Oct 1996 | A |
5565092 | Pannell et al. | Oct 1996 | A |
5565616 | Li et al. | Oct 1996 | A |
5571762 | Clerici et al. | Nov 1996 | A |
5571885 | Chung et al. | Nov 1996 | A |
5599381 | Whitlock | Feb 1997 | A |
5600043 | Johnston et al. | Feb 1997 | A |
5600045 | Van Der Aalst et al. | Feb 1997 | A |
5609654 | Le et al. | Mar 1997 | A |
5633419 | Spencer et al. | May 1997 | A |
5639930 | Penick | Jun 1997 | A |
5653956 | Zones | Aug 1997 | A |
5656149 | Zones et al. | Aug 1997 | A |
5661097 | Spencer et al. | Aug 1997 | A |
5663465 | Clegg et al. | Sep 1997 | A |
5663474 | Pham et al. | Sep 1997 | A |
5675046 | Ohno et al. | Oct 1997 | A |
5675052 | Menon et al. | Oct 1997 | A |
5679134 | Brugerolle et al. | Oct 1997 | A |
5679879 | Mercier et al. | Oct 1997 | A |
5684213 | Nemphos et al. | Nov 1997 | A |
5693191 | Pividal et al. | Dec 1997 | A |
5695890 | Thompson et al. | Dec 1997 | A |
5698747 | Godwin et al. | Dec 1997 | A |
5705712 | Frey et al. | Jan 1998 | A |
5705728 | Viswanathan et al. | Jan 1998 | A |
5705729 | Huang | Jan 1998 | A |
5708246 | Camaioni et al. | Jan 1998 | A |
5720858 | Noceti et al. | Feb 1998 | A |
5728897 | Buysch et al. | Mar 1998 | A |
5728905 | Clegg et al. | Mar 1998 | A |
5734073 | Chambers et al. | Mar 1998 | A |
5741949 | Mack | Apr 1998 | A |
5744669 | Kalnes et al. | Apr 1998 | A |
5750801 | Buysch et al. | May 1998 | A |
5770175 | Zones | Jun 1998 | A |
5776871 | Cothran et al. | Jul 1998 | A |
5780703 | Chang et al. | Jul 1998 | A |
5782936 | Riley | Jul 1998 | A |
5798314 | Spencer et al. | Aug 1998 | A |
5814715 | Chen et al. | Sep 1998 | A |
5817904 | Vic et al. | Oct 1998 | A |
5821394 | Schoebrechts et al. | Oct 1998 | A |
5847224 | Koga et al. | Dec 1998 | A |
5849978 | Benazzi et al. | Dec 1998 | A |
5866735 | Cheung et al. | Feb 1999 | A |
5882614 | Taylor, Jr. et al. | Mar 1999 | A |
5895831 | Brasier et al. | Apr 1999 | A |
5898086 | Harris | Apr 1999 | A |
5905169 | Jacobson | May 1999 | A |
5906892 | Thompson et al. | May 1999 | A |
5908963 | Voss et al. | Jun 1999 | A |
5928488 | Newman | Jul 1999 | A |
5952538 | Vaughn et al. | Sep 1999 | A |
5959170 | Withers, Jr. et al. | Sep 1999 | A |
5968236 | Bassine | Oct 1999 | A |
5969195 | Stabel et al. | Oct 1999 | A |
5977402 | Sekiguchi et al. | Nov 1999 | A |
5983476 | Eshelman et al. | Nov 1999 | A |
5986158 | Van Broekhoven et al. | Nov 1999 | A |
5994604 | Reagen et al. | Nov 1999 | A |
5998679 | Miller | Dec 1999 | A |
5998686 | Clem et al. | Dec 1999 | A |
6002059 | Hellring et al. | Dec 1999 | A |
6015867 | Fushimi et al. | Jan 2000 | A |
6018088 | Olah | Jan 2000 | A |
6022929 | Chen et al. | Feb 2000 | A |
6034288 | Scott et al. | Mar 2000 | A |
6056804 | Keefer et al. | May 2000 | A |
6068679 | Zheng | May 2000 | A |
6072091 | Cosyns et al. | Jun 2000 | A |
6087294 | Klabunde et al. | Jul 2000 | A |
6090312 | Ziaka et al. | Jul 2000 | A |
6093306 | Hanrahan et al. | Jul 2000 | A |
6096932 | Subramanian | Aug 2000 | A |
6096933 | Cheung et al. | Aug 2000 | A |
6103215 | Zones et al. | Aug 2000 | A |
6107561 | Thompson | Aug 2000 | A |
6117371 | Mack | Sep 2000 | A |
6124514 | Emmrich et al. | Sep 2000 | A |
6127588 | Kimble et al. | Oct 2000 | A |
6130260 | Hall et al. | Oct 2000 | A |
6143939 | Farcasiu et al. | Nov 2000 | A |
6169218 | Hearn et al. | Jan 2001 | B1 |
6180841 | Fatutto et al. | Jan 2001 | B1 |
6187871 | Thompson et al. | Feb 2001 | B1 |
6187983 | Sun | Feb 2001 | B1 |
6203712 | Bronner et al. | Mar 2001 | B1 |
6207864 | Henningsen et al. | Mar 2001 | B1 |
6225517 | Nascimento et al. | May 2001 | B1 |
6248218 | Linkous et al. | Jun 2001 | B1 |
6265505 | McConville et al. | Jul 2001 | B1 |
6281405 | Davis et al. | Aug 2001 | B1 |
6320085 | Arvai et al. | Nov 2001 | B1 |
6337063 | Rouleau et al. | Jan 2002 | B1 |
6342200 | Rouleau et al. | Jan 2002 | B1 |
6368490 | Gestermann | Apr 2002 | B1 |
6369283 | Guram et al. | Apr 2002 | B1 |
6372949 | Brown et al. | Apr 2002 | B1 |
6376731 | Evans et al. | Apr 2002 | B1 |
6380328 | McConville et al. | Apr 2002 | B1 |
6380423 | Banning et al. | Apr 2002 | B2 |
6380444 | Bjerrum et al. | Apr 2002 | B1 |
6395945 | Randolph | May 2002 | B1 |
6403840 | Zhou et al. | Jun 2002 | B1 |
6406523 | Connor et al. | Jun 2002 | B1 |
6423211 | Randolph et al. | Jul 2002 | B1 |
6426441 | Randolph et al. | Jul 2002 | B1 |
6426442 | Ichikawa et al. | Jul 2002 | B1 |
6452058 | Schweizer et al. | Sep 2002 | B1 |
6455650 | Lipian et al. | Sep 2002 | B1 |
6462243 | Zhou et al. | Oct 2002 | B1 |
6465696 | Zhou et al. | Oct 2002 | B1 |
6465699 | Grosso | Oct 2002 | B1 |
6472345 | Hintermann et al. | Oct 2002 | B2 |
6472572 | Zhou et al. | Oct 2002 | B1 |
6475463 | Elomari et al. | Nov 2002 | B1 |
6475464 | Rouleau et al. | Nov 2002 | B1 |
6479705 | Murata et al. | Nov 2002 | B2 |
6482997 | Petit-Clair et al. | Nov 2002 | B2 |
6486368 | Zhou et al. | Nov 2002 | B1 |
6491809 | Briot et al. | Dec 2002 | B1 |
6495484 | Holtcamp | Dec 2002 | B1 |
6509485 | Mul et al. | Jan 2003 | B2 |
6511526 | Jagger et al. | Jan 2003 | B2 |
6514319 | Keefer et al. | Feb 2003 | B2 |
6518474 | Sanderson et al. | Feb 2003 | B1 |
6518476 | Culp et al. | Feb 2003 | B1 |
6525228 | Chauvin et al. | Feb 2003 | B2 |
6525230 | Grosso | Feb 2003 | B2 |
6528693 | Gandy et al. | Mar 2003 | B1 |
6538162 | Chang et al. | Mar 2003 | B2 |
6540905 | Elomari | Apr 2003 | B1 |
6545191 | Stauffer | Apr 2003 | B1 |
6547958 | Elomari | Apr 2003 | B1 |
6548040 | Rouleau et al. | Apr 2003 | B1 |
6552241 | Randolph et al. | Apr 2003 | B1 |
6566572 | Okamoto et al. | May 2003 | B2 |
6572829 | Linkous et al. | Jun 2003 | B2 |
6585953 | Roberts et al. | Jul 2003 | B2 |
6616830 | Elomari | Sep 2003 | B2 |
6620757 | McConville et al. | Sep 2003 | B2 |
6632971 | Brown et al. | Oct 2003 | B2 |
6635793 | Mul et al. | Oct 2003 | B2 |
6641644 | Jagger et al. | Nov 2003 | B2 |
6646102 | Boriack et al. | Nov 2003 | B2 |
6669846 | Perriello | Dec 2003 | B2 |
6672572 | Werlen | Jan 2004 | B2 |
6679986 | Da Silva et al. | Jan 2004 | B1 |
6680415 | Gulotty, Jr. et al. | Jan 2004 | B1 |
6692626 | Keefer et al. | Feb 2004 | B2 |
6692723 | Rouleau et al. | Feb 2004 | B2 |
6710213 | Aoki et al. | Mar 2004 | B2 |
6713087 | Tracy et al. | Mar 2004 | B2 |
6713655 | Yilmaz et al. | Mar 2004 | B2 |
RE38493 | Keefer et al. | Apr 2004 | E |
6723808 | Holtcamp | Apr 2004 | B2 |
6727400 | Messier et al. | Apr 2004 | B2 |
6740146 | Simonds | May 2004 | B2 |
6753390 | Ehrman et al. | Jun 2004 | B2 |
6765120 | Weber et al. | Jul 2004 | B2 |
6797845 | Hickman et al. | Sep 2004 | B1 |
6797851 | Martens et al. | Sep 2004 | B2 |
6821924 | Gulotty, Jr. et al. | Nov 2004 | B2 |
6822123 | Stauffer | Nov 2004 | B2 |
6822125 | Lee et al. | Nov 2004 | B2 |
6825307 | Goodall | Nov 2004 | B2 |
6825383 | Dewkar et al. | Nov 2004 | B1 |
6831032 | Spaether | Dec 2004 | B2 |
6838576 | Wicki et al. | Jan 2005 | B1 |
6841063 | Elomari | Jan 2005 | B2 |
6852896 | Stauffer | Feb 2005 | B2 |
6866950 | Connor et al. | Mar 2005 | B2 |
6869903 | Matsunaga | Mar 2005 | B2 |
6875339 | Rangarajan et al. | Apr 2005 | B2 |
6878853 | Tanaka et al. | Apr 2005 | B2 |
6888013 | Paparatto et al. | May 2005 | B2 |
6900363 | Harth et al. | May 2005 | B2 |
6902602 | Keefer et al. | Jun 2005 | B2 |
6903171 | Rhodes et al. | Jun 2005 | B2 |
6909024 | Jones et al. | Jun 2005 | B1 |
6921597 | Keefer et al. | Jul 2005 | B2 |
6933417 | Henley et al. | Aug 2005 | B1 |
6946566 | Yaegashi et al. | Sep 2005 | B2 |
6953868 | Boaen et al. | Oct 2005 | B2 |
6953870 | Yan et al. | Oct 2005 | B2 |
6953873 | Cortright et al. | Oct 2005 | B2 |
6956140 | Ehrenfeld | Oct 2005 | B2 |
6958306 | Holtcamp | Oct 2005 | B2 |
6984763 | Schweizer et al. | Jan 2006 | B2 |
7001872 | Pyecroft et al. | Feb 2006 | B2 |
7002050 | Fernandez et al. | Feb 2006 | B2 |
7011811 | Elomari | Mar 2006 | B2 |
7019182 | Grosso | Mar 2006 | B2 |
7026145 | Mizrahi et al. | Apr 2006 | B2 |
7026519 | Fernandez et al. | Apr 2006 | B2 |
7037358 | Babicki et al. | May 2006 | B2 |
7045670 | Johnson et al. | May 2006 | B2 |
7049388 | Boriack et al. | May 2006 | B2 |
7053252 | Boussand et al. | May 2006 | B2 |
7057081 | Allison et al. | Jun 2006 | B2 |
7060865 | Ding et al. | Jun 2006 | B2 |
7064238 | Waycuilis | Jun 2006 | B2 |
7064240 | Ohno et al. | Jun 2006 | B2 |
7067448 | Weitkamp et al. | Jun 2006 | B1 |
7083714 | Elomari | Aug 2006 | B2 |
7084308 | Stauffer | Aug 2006 | B1 |
7091270 | Zilberman et al. | Aug 2006 | B2 |
7091387 | Fong et al. | Aug 2006 | B2 |
7091391 | Stauffer | Aug 2006 | B2 |
7094936 | Owens et al. | Aug 2006 | B1 |
7098371 | Mack et al. | Aug 2006 | B2 |
7105710 | Boons et al. | Sep 2006 | B2 |
7138534 | Forlin et al. | Nov 2006 | B2 |
7141708 | Marsella et al. | Nov 2006 | B2 |
7145045 | Harmsen et al. | Dec 2006 | B2 |
7148356 | Smith, III et al. | Dec 2006 | B2 |
7148390 | Zhou et al. | Dec 2006 | B2 |
7151199 | Martens et al. | Dec 2006 | B2 |
7161050 | Sherman et al. | Jan 2007 | B2 |
7169730 | Ma et al. | Jan 2007 | B2 |
7176340 | Van Broekhoven et al. | Feb 2007 | B2 |
7176342 | Bellussi et al. | Feb 2007 | B2 |
7182871 | Perriello | Feb 2007 | B2 |
7193093 | Murray et al. | Mar 2007 | B2 |
7196239 | Van Egmond et al. | Mar 2007 | B2 |
7199083 | Zevallos | Apr 2007 | B2 |
7199255 | Murray et al. | Apr 2007 | B2 |
7208641 | Nagasaki et al. | Apr 2007 | B2 |
7214750 | McDonald et al. | May 2007 | B2 |
7220391 | Huang et al. | May 2007 | B1 |
7226569 | Elomari | Jun 2007 | B2 |
7226576 | Elomari | Jun 2007 | B2 |
7230150 | Grosso et al. | Jun 2007 | B2 |
7230151 | Martens et al. | Jun 2007 | B2 |
7232872 | Shaffer et al. | Jun 2007 | B2 |
7238846 | Janssen et al. | Jul 2007 | B2 |
7244795 | Agapiou et al. | Jul 2007 | B2 |
7244867 | Waycuilis | Jul 2007 | B2 |
7250107 | Benazzi et al. | Jul 2007 | B2 |
7250542 | Smith, Jr. et al. | Jul 2007 | B2 |
7252920 | Kurokawa et al. | Aug 2007 | B2 |
7253327 | Janssens et al. | Aug 2007 | B2 |
7253328 | Stauffer | Aug 2007 | B2 |
7265193 | Weng et al. | Sep 2007 | B2 |
7267758 | Benazzi et al. | Sep 2007 | B2 |
7268263 | Frey et al. | Sep 2007 | B1 |
7271303 | Sechrist et al. | Sep 2007 | B1 |
7273957 | Bakshi et al. | Sep 2007 | B2 |
7282603 | Richards | Oct 2007 | B2 |
7285698 | Liu et al. | Oct 2007 | B2 |
7304193 | Frey et al. | Dec 2007 | B1 |
7342144 | Kaizik et al. | Mar 2008 | B2 |
7348295 | Zones et al. | Mar 2008 | B2 |
7348464 | Waycuilis | Mar 2008 | B2 |
7357904 | Zones et al. | Apr 2008 | B2 |
7361794 | Grosso | Apr 2008 | B2 |
7390395 | Elomari | Jun 2008 | B2 |
7560607 | Waycuilis | Jul 2009 | B2 |
7674941 | Waycuilis et al. | Mar 2010 | B2 |
20020102672 | Mizrahi | Aug 2002 | A1 |
20020193649 | O'Rear et al. | Dec 2002 | A1 |
20020198416 | Zhou et al. | Dec 2002 | A1 |
20030004380 | Grumann | Jan 2003 | A1 |
20030065239 | Zhu | Apr 2003 | A1 |
20030069452 | Sherman et al. | Apr 2003 | A1 |
20030078456 | Yilmaz et al. | Apr 2003 | A1 |
20030120121 | Sherman et al. | Jun 2003 | A1 |
20030125589 | Grosso | Jul 2003 | A1 |
20030166973 | Zhou et al. | Sep 2003 | A1 |
20040006246 | Sherman et al. | Jan 2004 | A1 |
20040062705 | Leduc | Apr 2004 | A1 |
20040152929 | Clarke | Aug 2004 | A1 |
20040158107 | Aoki | Aug 2004 | A1 |
20040158108 | Snoble | Aug 2004 | A1 |
20040171779 | Matyjaszewski et al. | Sep 2004 | A1 |
20040187684 | Elomari | Sep 2004 | A1 |
20040188324 | Elomari | Sep 2004 | A1 |
20040220433 | Van Der Heide | Nov 2004 | A1 |
20050027084 | Clarke | Feb 2005 | A1 |
20050038310 | Lorkovic et al. | Feb 2005 | A1 |
20050042159 | Elomari | Feb 2005 | A1 |
20050047927 | Lee et al. | Mar 2005 | A1 |
20050148805 | Jones | Jul 2005 | A1 |
20050171393 | Lorkovic | Aug 2005 | A1 |
20050192468 | Sherman et al. | Sep 2005 | A1 |
20050215837 | Hoffpauir | Sep 2005 | A1 |
20050234276 | Waycuilis | Oct 2005 | A1 |
20050234277 | Waycuilis | Oct 2005 | A1 |
20050245771 | Fong et al. | Nov 2005 | A1 |
20050245772 | Fong | Nov 2005 | A1 |
20050245777 | Fong | Nov 2005 | A1 |
20050267224 | Herling | Dec 2005 | A1 |
20060025617 | Begley | Feb 2006 | A1 |
20060100469 | Waycuilis | May 2006 | A1 |
20060135823 | Jun | Jun 2006 | A1 |
20060138025 | Zones | Jun 2006 | A1 |
20060138026 | Chen | Jun 2006 | A1 |
20060149116 | Slaugh | Jul 2006 | A1 |
20060229228 | Komon et al. | Oct 2006 | A1 |
20060229475 | Weiss et al. | Oct 2006 | A1 |
20060270863 | Reiling | Nov 2006 | A1 |
20060288690 | Elomari | Dec 2006 | A1 |
20070004955 | Kay | Jan 2007 | A1 |
20070078285 | Dagle | Apr 2007 | A1 |
20070100189 | Stauffer | May 2007 | A1 |
20070129584 | Basset | Jun 2007 | A1 |
20070142680 | Ayoub | Jun 2007 | A1 |
20070148067 | Zones | Jun 2007 | A1 |
20070148086 | Zones | Jun 2007 | A1 |
20070149778 | Zones | Jun 2007 | A1 |
20070149789 | Zones | Jun 2007 | A1 |
20070149819 | Zones | Jun 2007 | A1 |
20070149824 | Zones | Jun 2007 | A1 |
20070149837 | Zones | Jun 2007 | A1 |
20070197801 | Bolk | Aug 2007 | A1 |
20070197847 | Liu | Aug 2007 | A1 |
20070213545 | Bolk | Sep 2007 | A1 |
20070238905 | Arredondo | Oct 2007 | A1 |
20070238909 | Gadewar et al. | Oct 2007 | A1 |
20070276168 | Garel | Nov 2007 | A1 |
20070284284 | Zones | Dec 2007 | A1 |
20080022717 | Yoshida et al. | Jan 2008 | A1 |
20080183022 | Waycuilis | Jul 2008 | A1 |
20080188697 | Lorkovic | Aug 2008 | A1 |
20080200740 | Waycuilis | Aug 2008 | A1 |
20080275284 | Waycuilis | Nov 2008 | A1 |
20090005620 | Waycuilis et al. | Jan 2009 | A1 |
20090247796 | Waycuilis et al. | Oct 2009 | A1 |
20090308759 | Waycuilis | Dec 2009 | A1 |
20090312586 | Waycuilis et al. | Dec 2009 | A1 |
20090326292 | Waycuilis | Dec 2009 | A1 |
Number | Date | Country |
---|---|---|
0210054 | Aug 2004 | BR |
1099656 | Apr 1981 | CA |
1101441 | May 1981 | CA |
1202610 | Apr 1986 | CA |
2447761 | Nov 2002 | CA |
2471295 | Jul 2003 | CA |
2542857 | May 2005 | CA |
2236126 | Aug 2006 | CA |
2203115 | Sep 2006 | CA |
2510093 | Dec 2006 | CA |
0164798 | Dec 1985 | EP |
0418971 | Mar 1991 | EP |
0418974 | Mar 1991 | EP |
0418975 | Mar 1991 | EP |
0510238 | Oct 1992 | EP |
0526908 | Feb 1993 | EP |
0346612 | Aug 1993 | EP |
0560546 | Sep 1993 | EP |
0976705 | Jul 1998 | EP |
1186591 | Mar 2002 | EP |
1253126 | Oct 2002 | EP |
1312411 | May 2003 | EP |
1395536 | Mar 2004 | EP |
1404636 | Apr 2004 | EP |
1235769 | May 2004 | EP |
1435349 | Jul 2004 | EP |
1440939 | Jul 2004 | EP |
1474371 | Nov 2004 | EP |
1235772 | Jan 2005 | EP |
1661620 | May 2006 | EP |
1760057 | Mar 2007 | EP |
1689728 | Apr 2007 | EP |
1808227 | Jul 2007 | EP |
1837320 | Sep 2007 | EP |
5125 | Feb 1912 | GB |
156122 | Mar 1922 | GB |
294100 | Jun 1929 | GB |
363009 | Dec 1931 | GB |
402928 | Dec 1933 | GB |
474922 | Nov 1937 | GB |
536491 | May 1941 | GB |
553950 | Jun 1943 | GB |
586483 | Mar 1947 | GB |
775590 | May 1957 | GB |
793214 | Apr 1958 | GB |
796048 | Jun 1958 | GB |
796085 | Jun 1958 | GB |
883256 | Nov 1961 | GB |
883256 | Nov 1961 | GB |
950975 | Mar 1964 | GB |
950976 | Mar 1964 | GB |
991303 | May 1965 | GB |
995960 | Jun 1965 | GB |
1015033 | Dec 1965 | GB |
1104294 | Feb 1968 | GB |
1133752 | Nov 1968 | GB |
1172002 | Nov 1969 | GB |
1212240 | Nov 1970 | GB |
1233299 | May 1971 | GB |
1253618 | Nov 1971 | GB |
1263806 | Feb 1972 | GB |
1446803 | Aug 1976 | GB |
1542112 | Mar 1979 | GB |
2095243 | Sep 1982 | GB |
2095245 | Sep 1982 | GB |
2095249 | Sep 1982 | GB |
2116546 | Sep 1982 | GB |
2120249 | Nov 1983 | GB |
2185754 | Jul 1987 | GB |
2191214 | Dec 1987 | GB |
2004-529189 | Sep 2004 | JP |
694483 | Oct 1979 | SU |
8300859 | Mar 1983 | WO |
8504863 | Nov 1985 | WO |
8504867 | Nov 1985 | WO |
9008120 | Jul 1990 | WO |
9008752 | Aug 1990 | WO |
9118856 | Dec 1991 | WO |
9203401 | Mar 1992 | WO |
9212946 | Aug 1992 | WO |
9316798 | Sep 1993 | WO |
9622263 | Jul 1996 | WO |
9744302 | Nov 1997 | WO |
9812165 | Mar 1998 | WO |
9907443 | Feb 1999 | WO |
0007718 | Feb 2000 | WO |
0009261 | Feb 2000 | WO |
0114300 | Mar 2001 | WO |
0138275 | May 2001 | WO |
0144149 | Jun 2001 | WO |
02094749 | Nov 2002 | WO |
02094750 | Nov 2002 | WO |
02094751 | Nov 2002 | WO |
02094752 | Nov 2002 | WO |
03000635 | Jan 2003 | WO |
03002251 | Jan 2003 | WO |
03018524 | Mar 2003 | WO |
03020676 | Mar 2003 | WO |
03022827 | Mar 2003 | WO |
03043575 | May 2003 | WO |
03051813 | Jun 2003 | WO |
03062143 | Jul 2003 | WO |
03062172 | Jul 2003 | WO |
03078366 | Sep 2003 | WO |
2004018093 | Mar 2004 | WO |
2004067487 | Aug 2004 | WO |
2005014168 | Feb 2005 | WO |
2005019143 | Mar 2005 | WO |
2005021468 | Mar 2005 | WO |
2005035121 | Apr 2005 | WO |
2005037758 | Apr 2005 | WO |
2005054120 | Jun 2005 | WO |
2005056525 | Jun 2005 | WO |
2005058782 | Jun 2005 | WO |
2005090272 | Sep 2005 | WO |
2005095310 | Oct 2005 | WO |
2005105709 | Nov 2005 | WO |
2005105715 | Nov 2005 | WO |
2005110953 | Nov 2005 | WO |
2005104689 | Nov 2005 | WO |
2005113437 | Dec 2005 | WO |
2005113440 | Dec 2005 | WO |
2006007093 | Jan 2006 | WO |
2006015824 | Feb 2006 | WO |
2006019399 | Feb 2006 | WO |
2006020234 | Feb 2006 | WO |
2006036293 | Apr 2006 | WO |
2006039213 | Apr 2006 | WO |
2006039354 | Apr 2006 | WO |
2006043075 | Apr 2006 | WO |
2006053345 | May 2006 | WO |
2006-067155 | Jun 2006 | WO |
2006067188 | Jun 2006 | WO |
2006067190 | Jun 2006 | WO |
2006067191 | Jun 2006 | WO |
2006067192 | Jun 2006 | WO |
2006067193 | Jun 2006 | WO |
2006069107 | Jun 2006 | WO |
2006071354 | Jul 2006 | WO |
2006076942 | Jul 2006 | WO |
2006083427 | Aug 2006 | WO |
2006-100312 | Sep 2006 | WO |
2006104909 | Oct 2006 | WO |
2006104914 | Oct 2006 | WO |
2006111997 | Oct 2006 | WO |
2006113205 | Oct 2006 | WO |
2006118935 | Nov 2006 | WO |
2007001934 | Jan 2007 | WO |
2007017900 | Feb 2007 | WO |
2007044139 | Apr 2007 | WO |
2007046986 | Apr 2007 | WO |
2007050745 | May 2007 | WO |
2007071046 | Jun 2007 | WO |
2007079038 | Jul 2007 | WO |
2007091009 | Aug 2007 | WO |
2007094995 | Aug 2007 | WO |
2007107031 | Sep 2007 | WO |
2007111997 | Oct 2007 | WO |
2007114479 | Oct 2007 | WO |
2007125332 | Nov 2007 | WO |
2007130054 | Nov 2007 | WO |
2007130055 | Nov 2007 | WO |
2007141295 | Dec 2007 | WO |
2007142745 | Dec 2007 | WO |
2008036562 | Mar 2008 | WO |
2008036563 | Mar 2008 | WO |
2008106319 | Sep 2008 | WO |
2008157043 | Dec 2008 | WO |
2008157044 | Dec 2008 | WO |
2008157045 | Dec 2008 | WO |
2008157046 | Dec 2008 | WO |
2008157047 | Dec 2008 | WO |
2009152403 | Dec 2009 | WO |
2009152405 | Dec 2009 | WO |
2009152408 | Dec 2009 | WO |
Number | Date | Country | |
---|---|---|---|
20080171898 A1 | Jul 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10826885 | Apr 2004 | US |
Child | 11778479 | US |